Liminatus Pharma's total assets for Q2 2025 were $1.91M, an increase of Infinity% from the previous quarter. LIMN total liabilities were $10.72M for the fiscal quarter, a 1010861.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.